12:00 AM
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Enbrel etanercept regulatory update

EMA's CHMP issued a positive opinion to expand the label for Enbrel etanercept to include treatment of polyarthritis and extended oligoarthritis in pediatric patients >=2 years of age who have an inadequate response to...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >